LPL Financial LLC

Position in CYTK — Cytokinetics Inc

CIK 1403438 FORT MILL, SC

Position in CYTK

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,419,776

+$604,338 QoQ

Shares Held

16,666

+34.7% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#241

of 477 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 3% Shared 0% None 97%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. CYTK ranks #48 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,419,776	16,666	+34.7%	Shares	Sole	2026-08-07
2026-03-31	$815,438	12,372	+1.4%	Shares	Sole	2026-05-06
2025-12-31	$774,933	12,196	+8.9%	Shares	Sole	2026-02-11
2025-09-30	$615,606	11,201	-43.4%	Shares	Sole	2025-11-12
2025-06-30	$653,465	19,778	+33.1%	Shares	Sole	2025-08-12
2025-03-31	$597,263	14,861	+6.2%	Shares	Sole	2025-05-07
2024-12-31	$657,995	13,988	+6.6%	Shares	Sole	2025-02-11
2024-09-30	$692,630	13,118	+1.9%	Shares	Sole	2024-11-08
2024-06-30	$697,784	12,879	-7.7%	Shares	Sole	2024-08-07
2024-03-31	$977,824	13,947	+0.6%	Shares	Sole	2024-05-10
2023-12-31	$1,158,006	13,870	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.